Highlights
- 1
- 2European heart journal · 2022
- 3JAMA neurology · 2021
Publications
Funding
Active
8 grants- Co-IR01HL174863-01A1CAROTID-MAP Carotid Atherosclerotic Risk Assessment Through Imaging and PredictionNational Heart, Lung, and Blood Institute · 2025–2030 · via Columbia University
- Co-IR01NS140459-01A1Anticoagulation in Intracerebral Hemorrhage Survivors with Atrial Fibrillation and Imaging features of Cerebral Amyloid Angiopathy and Small Vessel DiseaseNational Institute of Neurological Disorders and Stroke · 2025–2030 · via Yale University
- MPIR01NS135205-01A1Quantitative cerebral oxygen metabolic imaging of acute ischemic strokeNational Institute of Neurological Disorders and Stroke · 2024–2029
- Sub-PIU01NS086872-13StrokeNet -NCCNational Institute of Neurological Disorders and Stroke · 2023–2028 · via University of Cincinnati· 2 renewals
- Co-IWELL 252161-01Brain Estrogen Imaging and Neuroendocrine Risk Identification: The Gateway to Alzheimer's Prevention in WomenWellcome Leap, Inc. · 2026–2027
- Sub-PIU01NS106513-05ASPIRE-per pt-Cincinnati - Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)National Institute of Neurological Disorders and Stroke · 2019–2027 · via University of Cincinnati· 2 renewals
- MPIR01NS123576-01A1Quantitative susceptibility mapping for stroke risk prediction of vulnerable carotid plaquesNational Institute of Neurological Disorders and Stroke · 2022–2027
- Co-IWELL 252161-01Brain Estrogen Imaging and Neuroendocrine Risk Identification: The Gateway to Alzheimer's Prevention in WomenWellcome Leap, Inc. · 2025–2026
Completed grants (13)
- PIR01HL144541-05MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)National Heart, Lung, and Blood Institute · 2019–2025
- Sub-PIU01NS095869-05Antithrombotic Therapy After Cryptogenic Stroke With Atrial Cardiopathy: ARCADIANational Institute of Neurological Disorders and Stroke · 2017–2025 · via Columbia University· 2 renewals
- Sub-PIU01NS110728-01ARCADIA CSI (Cognition and Silent Infarcts)National Institute of Neurological Disorders and Stroke · 2019–2024 · via University of Cincinnati· 2 renewals
- Sub-PIR01NS106014-01A1RECONFIG- REcovery of CONsciousness Following Intracerebral HemorrhaGeNational Institute of Neurological Disorders and Stroke · 2019–2024 · via Columbia University
- Co-IR01NS104143-04Development, Validation, and Application of a Stroke Policy Simulation ModelNational Institute of Neurological Disorders and Stroke · 2018–2023 · via Harvard University
- MPIOT2HL156812-02ACTIV-IV Inpatient PlatformNational Heart, Lung, and Blood Institute · 2020–2022 · via University of Cincinnati· 2 renewals
- PIR01NS097443-04Left Atrial AbNormality, ThromboEmbolism, and Race: Novel Risk Factors For StrokeNational Institute of Neurological Disorders and Stroke · 2016–2021
- PIK23NS082367-05Atrial Fibrillation Precursors May Be Novel Stroke Risk FactorsNational Institute of Neurological Disorders and Stroke · 2013–2019
- KPU01NS026835-06POINT Study Under Grant No. 1 U01 NS026835-01A1National Institute of Neurological Disorders and Stroke · 2013–2019 · via University of California, San FranciscoNo publications yet
- Co-IU01NS080824-05MISTIE III: A Phase III, Randomized, Open-Label, 500-Subject Clinical Trial of Minimally Invasive Surgery Plus rt-PANational Institute of Neurological Disorders and Stroke · 2013–2019 · via The Johns Hopkins University
- KPR01HL109282-05CVD in American Indians: Imaging and Cardiovascular CenterNational Heart, Lung, and Blood Institute · 2013–2018
- KPR01HL093086-05Cerebrovascular Disease and its Consequences in the Strong Study CohortNational Heart, Lung, and Blood Institute · 2009–2014 · via University of Washington, The
- KPU01HL065521-09S2Cardiovascular Evaluation for the SHS Phase VNational Heart, Lung, and Blood Institute · 2013–2013
Honors & distinctions
- Member · American Society for Clinical Investigation · 2026
Clinical research
Active
2 studies- PINCT05723926Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral AnticoagulationNA · Javelin Medical Ltd. · OPEN TO ACCRUAL (as of 2026)Atrial Fibrillation; Oral Anticoagulation; Stroke; Implant
- PINCT03907046Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and RecoveryPHASE3 · Yale University · OPEN TO ACCRUAL (as of 2020)Intracerebral Hemorrhage; Atrial Fibrillation
Completed & closed trials (3)
- PINCT05702034A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention After an Acute Ischemic Stroke or High-Risk Transient Ischemic AttackPHASE3 · Janssen Research & Development, LLC · CLOSED TO ACCRUAL (as of 2026)Ischemic Stroke; Ischemic Attack, Transient
- PIMRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of_x000D_ undeteRmined source (MRI DECIPHER)Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
- PIARCADIA-CSI (Cognition and Silent Infarcts)National Institute of Neurological Disorders & Stroke · IRB STUDY CLOSURE (as of 2023)
News mentions
- Age Does Not Appear to Drive Cardiovascular Risk in PregnancyMay 18, 2026
Underlying cardiovascular risk, rather than older age, drives complications such as venous thromboembolism, cardiomyopathy and heart failure during pregnancy, according to new Weill Cornell Medicine research.
- Weill Cornell Medicine Faculty Inducted into ASCIMarch 2, 2026
Two Weill Cornell Medicine physician-scientists, Dr. Hooman Kamel and Dr. Robert Peck, have been elected members of the American Society for Clinical Investigation (ASCI) for 2026.
- Awards & Honors: DecemberDecember 30, 2024
Awards, honors and achievements for the month of December.
- Apixaban No Better Than Aspirin for Preventing Stroke Recurrence in Patients with Atrial CardiopathyFebruary 7, 2024
A multi-center, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to results reported by researchers at Weill Cornell Medicine, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian.
- Post-Operative Atrial Fibrillation Associated with Higher Risk for Heart FailureJune 29, 2022
A new onset of a rapid or irregular heartbeat that develops after surgery, often within a few days, is associated with an increased risk for hospitalization for heart failure among patients undergoing both cardiac and noncardiac surgery, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Show 2 more mentions
- Cerebral Hemorrhage Associated with Risk of Future Strokes and Cardiac EventsMay 3, 2021
People who have experienced a cerebral hemorrhage or brain bleed have a two-fold increase in the risk of having an ischemic stroke (caused by an artery blockage) or heart attack, compared with members of the general population.
- African American Patients Have Higher Risk of Stroke Recurrence Compared with White PatientsFebruary 24, 2020
The short-term risk of a second stroke following an initial minor stroke is roughly 60 percent higher for black patients compared with white patients, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Media highlights
- FDA Approves Novel Bayer Drug To Reduce Recurrence Of StrokeSTAT · November 10, 2026
- New Type Of Blood Thinner Approved To Prevent Repeat StrokesThe Wall Street Journal · November 10, 2026
Mentoring
- EBElora BasuMD mentee · Class of 2022
- CSCarolyn StewartMD mentee · Class of 2022
External relationships
Ownership
Doug Labs INC · TETMedical INC
Advisory/Scientific Board Member
American Medical Association · Janssen Research & Development, LLC · Medtronic, Inc. · Population Health Research Institute · TETMedical INC
Other
AbbVie Inc. · Alnylam Pharmaceuticals, Inc. · Arthrosi Therapeutics INC · AstraZeneca · Bayer Corporation · Boehringer Ingelheim Pharmaceuticals, Inc. (Germany) · Eli Lilly and Company · GlaxoSmithKline · Novo Nordisk Pharmaceuticals, Inc.